您好,欢迎来到试剂信息网! [登录] [免费注册]
试剂信息网
位置:首页 > 产品库 > BDP5290
立即咨询
咨询类型:
     
*姓名:
*电话:
*单位:
Email:
*留言内容:
请详细说明您的需求。
*验证码:
 
BDP5290
本产品不向个人销售,仅用作科学研究,不用于任何人体实验及非科研性质的动物实验。
BDP5290图片
CAS NO:1817698-21-7
包装与价格:
包装价格(元)
10 mM * 1 mL in DMSO电议
5mg电议
10mg电议
25mg电议
50mg电议
100mg电议
200mg电议
500mg电议

产品介绍
BDP5290 是ROCKMRCK的有效抑制剂,对于ROCK1ROCK2MRCKαMRCKβIC50值分别为 5 nM,50 nM,10 nM 和 100 nM。
生物活性

BDP5290 is a potent inhibitor of bothROCKandMRCKwithIC50s of 5 nM, 50 nM, 10 nM and 100 nM forROCK1,ROCK2,MRCKαandMRCKβ, respectively.

IC50& Target[1]

ROCK1

5 nM (IC50)

ROCK2

50 nM (IC50)

MRCKα

10 nM (IC50)

MRCKβ

100 nM (IC50)

体外研究
(In Vitro)

The Kiof BDP5290 for MRCKα is 10 nM, which is slightly more than the Kiof 4 nM for MRCKβ. 3 μM BDP5290 completely inhibits myosin II light chain (MLC) phosphorylation induced by MRCKβ, but not by ROCK1 or ROCK2. At higher concentrations, BDP5290 reduces MLC phosphorylation (pMLC) to undetectable levels. BDP5290 reduces MDA-MB-231 invasion at all tested concentrations starting from 0.1 μM, with virtually complete inhibition at 10 μM. After 24 hours in the presence of BDP5290 cell viability is slightly reduced with an EC50 >10 μM. Wound closure is inhibited by >60% at 1 μM BDP5290, a concentration that has no effect on cell viability[2].

分子量

371.82

性状

Solid

Formula

C17H18ClN7O

CAS 号

1817698-21-7

运输条件

Room temperature in continental US; may vary elsewhere.

储存方式
Powder-20°C3 years
4°C2 years
In solvent-80°C6 months
-20°C1 month
溶解性数据
In Vitro: 

DMSO : 12.5 mg/mL(33.62 mM;Need ultrasonic)

配制储备液
浓度溶剂体积质量1 mg5 mg10 mg
1 mM2.6895 mL13.4474 mL26.8947 mL
5 mM0.5379 mL2.6895 mL5.3789 mL
10 mM0.2689 mL1.3447 mL2.6895 mL
*

请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液;一旦配成溶液,请分装保存,避免反复冻融造成的产品失效
储备液的保存方式和期限:-80℃, 6 months; -20℃, 1 month。-80℃ 储存时,请在 6 个月内使用,-20℃ 储存时,请在 1 个月内使用。